[1] 曾艳梅,张思泉,娄国强,等. 替比夫定阻断乙肝病毒宫内感染的临床研究. 中国临床药理学与治疗学,2010,15（4）:443-445.
[2] Zhang Y,Ren Y,Wu Y,et al. The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication. J Virol,2013,87（7）:8075-8084.
[3] 马萍,宋诗铎,王磊.阿德福韦治疗对慢性乙型肝炎患者Th细胞相关细胞因子水平及HBVDNA的影响. 中国感染控制杂志,2011,10（1）:15-17.
[4] Zhu X,Chen L,Fan W,et al. An intronic variant in the GRP78,a stress-associated gene,improves prediction for liver cirrhosis in persistent HBV carriers. PLoS One,2011;6（7）:e21997.
[5] 中华医学会肝病学分会和感染病学分会. 慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[6] 张小,兪海英,郭银燕,等. 阿德福韦酯治疗慢性乙型肝炎儿童外周血T淋巴细胞的变化. 实用肝脏病杂志,2013,16（6）:546-547.
[7] Shrivastava S,Trehanpati N,Patra S,et al. Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in hepatitis B virus-positive newborns. J Viral Hepat,2013,20（8）：582-591.
[8] 廖丹,张秀兰,王滏,等.慢性乙型肝炎病毒携带者抗病毒治疗的临床疗效观察. 广西中医学院学报,2004,7（3）:41-42
[9] Lee YH,Bae SC,Song GG,et al. Hepatitis B virus （HBV） reactivation in rheumatic patients with hepatitis core antigen （HBV occult carriers）undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol,2013,31（1）:118-121.
[10] 詹辉,王剑松,武城闯,等.CD3 + T 淋巴细胞在膀胱癌肿瘤上皮与癌旁尿路上皮中的分布差异研究. 昆明医科大学学报,2014,35（1）:28-31.
[11] Bashour KT,Gondarenko A,Chen H,et al. CD28 and CD3 have complementary roles in T-cell traction forces. PNAS,2014,111（2）:2241-2246. |
